Skip to main content
Clinical Trials/NCT05030922
NCT05030922Active, not recruitingNot Applicable

Cardiovascular Risk Reduction-Diet in Pregnancy - Follow up 20 Years After the "CARRDIP"-Trial

Per Ole Iversen, MD2 sites in 1 country538 target enrollmentStarted: December 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
538
Locations
2
Primary Endpoint
Cardiovascular health score

Study Overview

Brief Summary

The "Cardiovascular Risk Reduction-Diet in Pregnancy" (CARRDIP) - is a randomised controlled trial with dietary intervention during pregnancy. The participants were enrolled in Norway 20 years ago and consisted of 269 pregnant, healthy mothers. The participants were randomised 1:1 to either intervention-diet or control. The intervention diet was build upon an anti-atherogenic principle and was a so called "Mediterranean diet". The participants were monitored during pregnancy, and mother and child participated in a follow-up study 1 year after birth. The current "CARRDIP20" trial is a follow-up of the same participants, both mother and offspring, 20 years after the original intervention to measure and analyse the cardiovascular health and compare the intervention group to the control group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • from original CARRDIP-trial:
  • Non-smoking pregnant women
  • BMI 19 to 32 kg/m2 at inclusion
  • Age 21 to 38 years
  • Carrying a single foetus

Exclusion Criteria

  • Previous pregnancy complications

Arms & Interventions

Diet intervention

Experimental

Follow up of both mother and offspring 20 years after allocation to an antiatherogenic diet during pregnancy.

Intervention: Antiatherogenic diet (Other)

Control

No Intervention

Follow up of both mother and offspring 20 years after allocation to control group during pregnancy.

Outcomes

Primary Outcomes

Cardiovascular health score

Time Frame: 1 day

Cardiovascular risk score by use of the most appropriate available risk score algorithm available at time of analysis, at present the preferred calculator is Life's Simple 7 - The American Heart Association https://doi.org/10.1161/CIRCULATIONAHA.109.192703

Secondary Outcomes

  • Body fat percentage(1 day)
  • Ultrasound examination of liver(1 day)
  • Ultrasound examination of carotid artery(1 day)
  • Blood samples - Glukose metabolism(1 day)
  • Mean arterial pressure (MAP)(1 day)
  • Anthropometry(1 day)
  • Blood samples - Lipid profile(1 day)

Investigators

Sponsor
Per Ole Iversen, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Per Ole Iversen, MD

Professor

University of Oslo

Study Sites (2)

Loading locations...

Similar Trials